04Jun
Cannabis-Derived Ingredients in FDA-Regulated Products: More Questions than Answers at FDA’s May 2019 Public Hearing
As most folks with any interest in the burgeoning cannabidiol (CBD) industry likely know, on May 31, 2019, the Food and Drug Administration held a public hearing “to obtain scientific data and information about the safety, manufacturing, product...
By:
Mintz - Consumer Product Safety Viewpoints
Related
Companies' Owner Subjected a Female Employee to Sexual Harassment, Then Fired Her for Complaining, F...
Read More >
The U.S. Department of Labor unveiled its long-awaited final rule on the overtime “white collar” e...
Read More >
There’s little debate: California is facing a housing crisis. The dispute lies in finding solutions...
Read More >
More than a decade ago in the seminal case Gantler v. Stephens, the Delaware Supreme Court clarified...
Read More >
Do you think that there is a difference between “furnishing” labor and “performing” labor? (Is t...
Read More >
In a stark reminder of the sanctity of Coast Guard investigations, and the consequences of impeding ...
Read More >